Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2024-03-20 Legal Proceedings Report
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
METabolic EXplorer : Ouverture d'une procédure de redressement judiciaire au bénéfice de METEX NØØVISTAGO. Report de l'arrêté des comptes annuels 2023.
Legal Proceedings Report Classification · 1% confidence The document is a press release dated March 20, 2024, announcing two key events: 1) The opening of receivership proceedings ('procédure de redressement judiciaire') for its subsidiary METEX NØØVISTAGO, and 2) The postponement of the approval of the 2023 annual accounts ('Report de l'arrêté des comptes annuels 2023'). It states the company will try to publish its annual financial report by June 30, 2024. Since this is an announcement about significant legal/financial events and the postponement of the annual report, it is not the full 10-K itself. It is a general regulatory announcement concerning legal proceedings and financial reporting delays. Given the content focuses heavily on legal proceedings ('redressement judiciaire') and financial status updates, it fits best under Legal Proceedings Report (LTR) or a general Regulatory Filing (RNS). Because the primary, immediate news is the legal action (receivership), LTR is a strong candidate, but since it also discusses the delay of the annual report and is structured as a general market update, RNS (Regulatory Filings - fallback) is often used for such mixed, time-sensitive announcements that aren't standard periodic reports or specific transaction disclosures. However, the mention of 'procédure de redressement judiciaire' strongly points towards legal matters. Given the options, LTR covers the most significant event described. If LTR is too specific, RNS is the fallback. I will classify it as LTR due to the explicit mention of judicial proceedings, which is a core component of that category.
2024-03-20 French
METabolic EXplorer sollicite l'ouverture d'une procédure de sauvegarde
Legal Proceedings Report Classification · 1% confidence The document is a press release dated March 12, 2024, announcing that METabolic EXplorer is seeking the opening of 'procédure de sauvegarde' (safeguard procedure) and 'procédures de redressement judiciaire' (reorganization proceedings) for its subsidiaries. This type of announcement relates to significant financial distress, restructuring, or potential insolvency proceedings. This does not fit neatly into standard periodic reports (10-K, IR, ER) or specific corporate actions (DIV, CAP, SHA). It is a critical, non-standard regulatory announcement concerning the company's financial viability and legal status. Given the options, this is best classified as a general Regulatory Filing (RNS) as it is a mandatory disclosure of a major event that doesn't match the other specific categories like Director's Dealing, M&A, or Dividend notices. It is not a report itself, but an announcement of a legal/financial action.
2024-03-12 French
Suspension de la cotation du titre METEX
Delisting Announcement Classification · 1% confidence The document is a very short announcement (2251 characters) dated March 12, 2024, stating that METEX has requested the suspension of its stock trading on Euronext Paris pending the upcoming release of a press release. This structure—a brief notice about an impending release or event without containing the full details of a major report (like 10-K, IR, or ER)—fits the definition of a Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since the announcement is specifically about the *suspension of trading* pending a future communication, it is a regulatory action announcement. Given the options, it is a general regulatory announcement that doesn't fit the specific financial report types (10-K, IR, ER) or specific corporate actions (DIV, CAP, DIRS). Therefore, the most appropriate fallback is Regulatory Filings (RNS), as it is a formal, non-standard announcement to the market regarding trading status.
2024-03-12 French
Chiffre d'affaires consolidé du 4è trimestre 2023
Earnings Release Classification · 1% confidence The document is titled 'Chiffre d'affaires consolidé du 4 è trimestre 2023' (Consolidated revenue for the 4th quarter of 2023) and provides detailed quarterly and full-year financial figures (revenue breakdown by Specialties and Commodities) for the period ending December 31, 2023. It discusses financial performance, cash position, and outlook. This content structure, focusing on detailed periodic financial results, strongly indicates an Interim/Quarterly Report (IR). It is not the full Annual Report (10-K) as it explicitly points to the 'Résultats annuels consolidés 2023' release date on March 28, 2024. It is too detailed to be just an Earnings Release (ER), which usually contains only key highlights. Therefore, the classification is Interim / Quarterly Report (IR). Q4 2023
2024-02-15 French
Calendrier financier 2024
Report Publication Announcement Classification · 1% confidence The document is titled "Calendrier financier 2024" (2024 Financial Calendar) and explicitly lists future dates for key corporate events such as Q4 2023 Revenue, Full Year 2023 Results, Q1 2024 Revenue, Annual General Meeting (AGM), and Half-Year 2024 Results. This document is an announcement detailing the schedule of future report publications and meetings, rather than being one of the reports itself (like 10-K or ER). Since it announces the timing of report releases, it fits the definition of a Report Publication Announcement (RPA). It also mentions the AGM date, but the primary purpose is the schedule of all financial releases.
2024-01-11 French
Bilan semestriel du contrat de liquidité de la société METABOLIC EXPLORER
Transaction in Own Shares Classification · 1% confidence The document is titled "Bilan semestriel du contrat de liquidité de la société METABOLIC EXPLORER" (Half-yearly balance sheet of the liquidity contract of the company METABOLIC EXPLORER) and reports on the status of a liquidity contract managed by Kepler Cheuvreux as of December 31, 2023. It details the number of shares, cash balance, and transaction volumes (buys and sells) over the preceding six months, comparing the current state to the previous balance sheet date (June 30, 2023). This type of regular reporting on share repurchase/liquidity management activities aligns directly with the definition of 'Transaction in Own Shares' (POS), which covers share repurchase programs, even when framed as a liquidity contract report. It is not a full financial report (10-K or IR), nor is it a general earnings release (ER).
2024-01-09 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.